Avecho Biotechnology Limited (OEZ) Stock Statistics & Valuation Metrics

Avecho Biotechnology Limited has a market cap or net worth of €8.18M. The enterprise value is ―.

Avecho Biotechnology Limited has 3,173,463,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Avecho Biotechnology Limited’s return on equity (ROE) is -0.95 and return on invested capital (ROIC) is -114.03%.

The current PE Ratio of Avecho Biotechnology Limited is -2.00. Avecho Biotechnology Limited’s PEG ratio is -0.45.

In the last 12 months, Avecho Biotechnology Limited had revenue of 1.13M and earned -3.12M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -3.97M and capital expenditures 0.00, giving a free cash flow of -3.97M billion.

Avecho Biotechnology Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Avecho Biotechnology Limited upcoming earnings date is Sep 1, 2025, TBA Not Confirmed.

Avecho Biotechnology Limited as a current ratio of 2.81, with Debt / Equity ratio of 32.93%

In the past 12 months, Avecho Biotechnology Limited has paid 0.00 in taxes.

Avecho Biotechnology Limited EV to EBITDA ratio is -1.69, with an EV/FCF ratio of -1.25.

Avecho Biotechnology Limited has €2.37M in cash and marketable securities with AU$1.08M in debt, giving a net cash position of -€1.30M billion.

Gross margin is 59.32%, with operating margin of -437.79%, and net profit margin of -275.64%.

The average price target for Avecho Biotechnology Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―